Kreitzer Anatol

Chief Discovery OfficerMapLight Therapeutics, Inc. (MPLT) · full profile →Form 4 · filed Jul 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2026Sell(S)14K$37.70$533K175K
Jul 17, 2026Sell(S)3K$37.05$105K189K
Jul 17, 2026Sell(S)200$38.39$8K175K
Jul 16, 2026Sell(S)2K$37.44$60K192K
Jul 16, 2026Sell(S)7K$36.66$274K194K
Jul 15, 2026Sell(S)6K$36.13$200K206K
Jul 15, 2026Sell(S)5K$36.94$167K201K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002021238-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.